
pmid: 20545967
Because of changes in life expectancy, there is an increasing number of elderly patients with esophageal cancer. The aim of this study was to assess the outcome of esophagectomy for cancer in patients 80 years or older. A retrospective review was performed of the records of all patients who underwent esophagectomy for cancer from 1992 to 2007. A cardiac and pulmonary evaluation was obtained on an individual basis in the younger patients and in all octogenarians. Among 560 patients with esophagectomy for cancer, 47 patients (8%) were octogenarians. The median age of the younger group (n= 513) was 63 years (interquartile range 56-71). Octogenarians had significantly more stage III disease (49% vs 31%, P= 0.02) but received less neoadjuvant therapy than younger patients (2% vs 21%, P= 0.0004). In octogenarians, the transhiatal resection was more common than in the younger group (79% vs 36%, P < 0.0001). Weight loss prior to surgery was similar in both groups, but body mass index was significantly lower in octogenarians (25 vs 28 kg/m(2) , P= 0.0002). Major complications occurred in 26% in octogenarians and 31% in the younger group (P= 0.51). Hospital mortality was similar (9% for octogenarians vs 4% in the younger group, P= 0.13). The median postoperative hospital stay was similar at 16 days (P= 0.69). There was no difference in cancer-related survival (median survival 48.9 vs 59.3 months, P= 0.31 log-rank test). Esophagectomy can be performed safely in carefully selected octogenarians with good cardiac and pulmonary function. Patients should not be denied an esophagectomy based only on their age.
Aged, 80 and over, Comparative Effectiveness Research, Esophageal Neoplasms, Age Factors, Adenocarcinoma, Middle Aged, Neoadjuvant Therapy, Body Mass Index, Respiratory Function Tests, Esophagectomy, Survival Rate, Postoperative Complications, Treatment Outcome, Heart Function Tests, Humans, Karnofsky Performance Status, Aged, Neoplasm Staging, Retrospective Studies
Aged, 80 and over, Comparative Effectiveness Research, Esophageal Neoplasms, Age Factors, Adenocarcinoma, Middle Aged, Neoadjuvant Therapy, Body Mass Index, Respiratory Function Tests, Esophagectomy, Survival Rate, Postoperative Complications, Treatment Outcome, Heart Function Tests, Humans, Karnofsky Performance Status, Aged, Neoplasm Staging, Retrospective Studies
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 44 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
